Related content

Safety and continuity of second and thirdline therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 466-472

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of 5fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer

By Inoue   Okigami   Kawamoto   Okugawa   Hiro   Saigusa   Toiyama   Tanaka   Mohri   Kusunoki  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 511-516

Spandidos Publications

Access to resources Recommend Favorite

A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma

By                      

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 591-595

Spandidos Publications

Access to resources Recommend Favorite

Radiotherapy and chemoradiotherapy as a novel option for the treatment of locally advanced inoperable gastric adenocarcinoma: A phase II study

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1150-1154

Spandidos Publications

Access to resources Recommend Favorite

Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced nonsmallcell lung cancer: A metaanalysis of randomized controlled trials

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 146-150

Spandidos Publications

Access to resources Recommend Favorite